RxSight, Inc.
General ticker "RXST" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $331.2M (TTM average)
RxSight, Inc. does not follow the US Stock Market performance with the rate: -18.7%.
Estimated limits based on current volatility of 3.9%: low 5.61$, high 6.06$
Factors to consider:
- Total employees count: 461 (-7.4%) as of 2025
- Top business risk factors: Failure to achieve profitability, Raising capital difficulties, Failure to market rxsight system, Market competition, Regulatory and compliance
- Current price 16.2% below estimated low
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [6.71$, 16.13$]
- 2026-12-31 to 2027-12-31 estimated range: [7.35$, 17.00$]
Financial Metrics affecting the RXST estimates:
- Positive: with PPE of -11.7 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: negative Operating cash flow
- Positive: Investing cash flow per share per price, % of 3.70 > 2.08
- Negative: negative Industry operating cash flow (median)
- Negative: 0.47 < Industry inventory ratio change (median), % of 0.70
- Negative: 0 < Interest expense per share per price, % of 0
Short-term RXST quotes
Long-term RXST plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $89.08MM | $139.93MM | $134.48MM |
| Operating Expenses | $139.16MM | $176.78MM | $182.67MM |
| Operating Income | $-50.09MM | $-36.86MM | $-48.19MM |
| Non-Operating Income | $1.50MM | $9.45MM | $9.31MM |
| Interest Expense | $3.31MM | $0.02MM | $0.02MM |
| R&D Expense | $29.05MM | $34.37MM | $38.55MM |
| Income(Loss) | $-48.59MM | $-27.41MM | $-38.88MM |
| Taxes | $0.02MM | $0.05MM | $0.07MM |
| Net Income(Loss)* | $-48.61MM | $-27.45MM | $-38.94MM |
| Stockholders Equity | $160.36MM | $281.24MM | $275.68MM |
| Inventory | $17.42MM | $22.01MM | $31.56MM |
| Assets | $182.55MM | $318.56MM | $311.81MM |
| Operating Cash Flow | $-41.59MM | $-16.95MM | $-15.51MM |
| Capital expenditure | $4.81MM | $5.44MM | $3.83MM |
| Investing Cash Flow | $-22.13MM | $-99.31MM | $16.89MM |
| Financing Cash Flow | $61.52MM | $123.32MM | $1.86MM |
| Earnings Per Share** | $-1.41 | $-0.71 | $-0.95 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.